TY  - GEN
AU  - Bellet, Meritxell
AU  - Ahmad, Faten
AU  - Villanueva, Rafael
AU  - Valdivia, Carolina
AU  - Palomino-Doza, Julian
AU  - Ruiz, Ada
AU  - Gonzalez, Xavier
AU  - Adrover, Encarna
AU  - Azaro, Analia
AU  - Valls-Margarit, Maria
AU  - Parra, Josep Lluis
AU  - Aguilar, Juan
AU  - Vidal, Maria
AU  - Martin, Anastasi
AU  - Gavila, Joaquin
AU  - Escriva-de-Romani, Santiago
AU  - Perello Martorell, Antonia
AU  - Hernando, Cristina
AU  - Lahuerta, Ainhara
AU  - Zamora, Pilar
AU  - Reyes, Victoria
AU  - Alcalde, Maria
AU  - Masanas, Helena
AU  - Celiz, Pamela
AU  - Ruiz, Isabel
AU  - Gil, Miguel
AU  - Segui, Miguel Angel
AU  - de la Pena, Lorena
PY  - 2019
DO  - 10.1177/1758835919833867
SN  - 1758-8340
UR  - https://hdl.handle.net/20.500.12105/22805
AB  - Drug-drug interactions are of significant concern in clinical practice in oncology, particularly in patients receiving Cyclin-dependent kinase (CDK) 4/6 inhibitors, which are typically exposed to long-term regimens. This article presents the...
LA  - eng
PB  - SAGE Publishing
KW  - CDK inhibitors
KW  - Palbociclib
KW  - Ribociclib
KW  - Breast cancer
TI  - Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
TY  - review article
ER  -